Evidence map›Paper›PMID 39065672›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Identification of South African Plant-Based Bioactive Compounds as Potential Inhibitors against the SARS-CoV-2 Receptor.

Nqobile Monate Mkolo, Clarissa Marcelle Naidoo, Rose Kadye, Chikwelu Lawrence Obi, Benson Chucks Iweriebor, Oyinlola Oluwunmi Olaokun, Earl Prinsloo, Muhammad Sulaiman Zubair

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nqobile Monate MkoloDepartment of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.
Clarissa Marcelle NaidooDepartment of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.
Rose KadyeDepartment of Biotechnology, Rhodes University, Makhanda 6140, South Africa.ORCID 0000-0001-8695-8137
Chikwelu Lawrence ObiDepartment of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.
Benson Chucks IwerieborDepartment of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.
Oyinlola Oluwunmi OlaokunDepartment of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.ORCID 0000-0002-8004-3187
Earl PrinslooDepartment of Biotechnology, Rhodes University, Makhanda 6140, South Africa.ORCID 0000-0002-3048-4304
Muhammad Sulaiman ZubairDepartment of Pharmacy, University of Tadulako, Palu 94118, Indonesia.

Funding

South African Medical Research Council (SAMRC) through its Division of Research Capacity Development RCDI MKOLO NM 21/24
6 · The paper itself

Abstract

The expected progress in SARS-CoV-2 vaccinations, as anticipated in 2020 and 2021, has fallen short, exacerbating global disparities due to a lack of universally recognized "safe and effective" vaccines. This study focuses on extracts of South African medicinal plants,

Indexed as

25-hydroxyvitamin D3-26,23-lactone6″-O-acetylglycitinangiotensin-converting enzyme 2 (ACE2)anti-COVID bioactive compoundsArtemisia afraArtemisia annuasesaminol glucosidespike (S) glycoproteintryptanthrin

Identifiers

PMID39065672
PMCPMC11279959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.